-
Includes medication cost,
access to provider and free shipping -
Customized for individuals with vitamin B6
which can support energy levels, digestion and nausea -
Ongoing care at no additional cost -
No insurance required -
No hidden fees
*Safety info: GLP-1 drugs may have serious side effects, including possible thyroid tumors. Do not use GLP-1 drugs if you or your family have a history of thyroid cancer called MTC or MEN 2. See more important safety information.
Lose up to
20%
of your body weight
On average, people on semaglutide or tirzepatide lose up to 20% of their weight in a year*.
Your current weight:
You could lose up to:
*In a 68-week and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in participants without diabetes and with a BMI of more than 30, or BMI of more than 27 with a weight-related condition, the average weight loss was 15% and 20% of body weight, when combined with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone). These clinical trials used the investigational products, semaglutide and tirzepatide, versions which were later approved under the brand names Wegovy and Zepbound.
*In a 68-week and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in participants without diabetes and with a BMI of more than 30, or BMI of more than 27 with a weight-related condition, the average weight loss was 15% and 20% of body weight, when combined with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone). These clinical trials used the investigational products, semaglutide and tirzepatide, versions which were later approved under the brand names Wegovy and Zepbound.


















